Earnings Summary

Tandem Diabetes Care, Inc.’s revenue fell -2.17% since last year same period to $195.92Mn in the Q2 2023. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated -23.43% fall in its revenue since last 3-months.

Tandem Diabetes Care, Inc.’s net profit fell -137.61% since last year same period to $-35.78Mn in the Q2 2023. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated 71.12% jump in its net profits since last 3-months.

Tandem Diabetes Care, Inc.’s net profit margin fell -142.88% since last year same period to -18.26% in the Q2 2023. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated 62.28% jump in its net profit margins since last 3-months.

Tandem Diabetes Care, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.05 - a 0% jump from last quarter’s estimates.

Tandem Diabetes Care, Inc.’s earning per share (EPS) estimates for the current year stand at -0.05.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Tandem Diabetes Care, Inc.’s return on assets (ROA) stands at -0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Tandem Diabetes Care, Inc.’s return on equity (ROE) stands at -0.58.